AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9383183
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg losartan (plus 12.5 mg hydrochlorothiazide if necessary)
Trial: 31829767
Drug: Hepatitis-B virus
RxNorm normalized name: hepatitis B virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis-B virus vaccine (control)
Trial: 28155569
Drug: Subconjunctival injection
RxNorm normalized name: STREPTOMYCES GRISEUS 0.05 g in 1 mL SUBCONJUNCTIVAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subconjunctival injection of demethylvancomycin
Trial: 16451393
Drug: Oral deferiprone
RxNorm normalized name: Deferiprone
DrugBank: Deferiprone (DB08826)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral deferiprone (L1)
Trial: 31567714
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg of 5% TXA in 100 mL of isotonic saline solution
Trial: 12527962
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (OC) users
Trial: 31398987
Drug: Oral sulfate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sulfate formula (SIR) in split-dose regimen
Trial: 22781352
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Nucleoside analogue and Alpha interferon)
Trial: 3318598
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg 4 times a day for 3 days)
Trial: 12702905
Drug: Individualized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized treatment (group A) - prolonged IFN therapy to maintain negative serum HBV-DNA levels for 6 months
Trial: 11073745
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (5 mg/kg/d)
Trial: 23059701
Drug: Behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural therapy plus usual care
Trial: 10371571
Drug: PEG interleukin-2
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEG interleukin-2 (2 million IU/m2 intravenous bolus every 2 months from week 2 to week 50)
Trial: 18587236
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day oral folic acid
Trial: 9732167
Drug: Itraconazole 400
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole 400 mg
Trial: 1580920
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of parenteral therapy (n=11 cases)
Trial: 30775426
Drug: roflumilast 500
RxNorm normalized name: ROFLUMILAST 500MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roflumilast 500 ug daily
Trial: 19606690
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conservative treatment)
Trial: 23918953
Drug: Supportive-expressive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-expressive group therapy (SET)
Trial: 21114549
Drug: karaya saponin
RxNorm normalized name: KARAYA
DrugBank: Karaya gum (DB10535)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: karaya saponin (various doses)
Trial: 12378376
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for hypertension in microalbuminuric patients
Trial: 30907187
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 2PN rate
Trial: 29629400
Drug: Aclidinium bromide
RxNorm normalized name: Aclidinium Bromide
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Aclidinium bromide 400 µg twice daily
Trial: 26974022
Drug: IT hydromorphone
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT hydromorphone at ED90 of 75 μg
Trial: 26974022
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine at ED90 of 150 μg
Trial: 26974022
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine (ED90 or higher)
Trial: 7408527
Drug: Indoprofen 400
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indoprofen 400 mg, 3 times a day for 1 week
Trial: 19205719
Drug: Eyelid scrub
RxNorm normalized name: Ocusoft Eyelid Scrub Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eyelid scrub in addition to topical levofloxacin
Trial: 2530251
Drug: Acitretin 50
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin 50 mg daily
Trial: 9869503
Drug: Tedisamil dihydrochloride
RxNorm normalized name: Levocetirizine Dihydrochloride
DrugBank: Tedisamil (DB06200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tedisamil dihydrochloride administered intravenously
Trial: 2530251
Drug: Acitretin 25
RxNorm normalized name: acitretin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin 25 mg daily
Trial: 26176357
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of video distraction plus parental presence (group VP)
Trial: 19405825
Drug: Non-submerged hollow
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-submerged hollow cylindrical and solid-screw implants with titanium plasma-sprayed surface
Trial: 6373961
Drug: B subunit
RxNorm normalized name: Modified Cholera toxin B subunit
DrugBank: Modified Cholera toxin B subunit (DB18557)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B subunit (high dose, 5.0 mg)
Trial: 28742932
Drug: Integrated 12-Step
RxNorm normalized name: STEP 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated 12-Step facilitation (iTSF) treatment
Trial: 21479749
Drug: Etodolac controlled
RxNorm normalized name: Etodolac
DrugBank: Etodolac (DB00749)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etodolac controlled porosity osmotic pump (CPOP) tablets (F4-34)
Trial: 23770005
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg golimumab
Trial: 6322961
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy plus razoxane (weekly schedule: 1 gram per square meter BSA every 8 hours for two doses per week)
Trial: 28771784
Drug: 6-mercaptopurine treatment
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6-mercaptopurine treatment intensifications
Trial: 30511840
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (n = 42, 4 capsules/day, equivalent to 2.5 g of α‐linolenic acid)
Trial: 23359034
Drug: Low-dose iterative
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose iterative reconstruction (LD-IR)
Trial: 28506305
Drug: Chemotherapy counseling
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy counseling module by pharmacists
Trial: 12207074
Drug: Ulinastatin (UTI)
RxNorm normalized name: phenazopyridine hydrochloride Oral Tablet [UTI Relief]
DrugBank: Ulinastatin (DB12038)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin (UTI) administered intravenously at a dose of 150,000 U every 12 h from the start of surgery until postoperative day 5
Trial: 3125794
Drug: Histologic examination
RxNorm normalized name: piperonyl butoxide
DrugBank: Piperonyl butoxide (DB09350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Histologic examination after treatment with arachidonic acid
Trial: 19485286
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical cyclosporin A
Trial: 6801218
Drug: Previous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previous treatment protocol (standardized protocol without aggressive ICP treatment)
Trial: 19020533
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium supplementation (MgCl(2)) 2.5 g (equivalent to 450 mg of elemental magnesium) for 4 months
Trial: 16504997
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg orally once daily for 3 days
Trial: 12898459
Drug: Testosterone (T)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (T) alone (50 to 75 mg, intramuscular [IM])
Trial: 12898459
Drug: Combined Testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined Testosterone (T) and Growth Hormone (GH) treatment
Trial: 26187277
Drug: Non-TCM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-TCM treatment for fractures (control group).
Trial: 24408162
Drug: Ponesimod 40
RxNorm normalized name: ponesimod
DrugBank: Ponesimod (DB12016)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ponesimod 40 mg (up-titration schedule)
Trial: 1493666
Drug: 12,000 U
RxNorm normalized name: epoetin alfa 12,000 UNT per 0.6 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12,000 U calcium heparin s.c. every 24 h (group 2)
Trial: 20827544
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (short arm cast until fracture union achieved)
Trial: 29792908
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg caffeine
Trial: 7668872
Drug: Chemotherapy in
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy in colon cancer cases with highly positive lymph node metastasis and positive lymphatic vessel invasion.
Trial: 9794673
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of mifepristone
Trial: 25572140
Drug: Daptomycin 6
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin 6 mg/kg IV bolus injection (10 s)
Trial: 12389003
Drug: Nifedipine capsules
RxNorm normalized name: Nifedipine Capsules
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine capsules (10 mg)
Trial: 19465485
Drug: High-frequency octreotide
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency octreotide (30 mg/21 days)
Trial: 7772487
Drug: CyA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CyA therapy following corticosteroid treatment
Trial: 2878598
Drug: Twice-daily bevantolol
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily bevantolol (200 mg)
Trial: 20135139
Drug: Bevacizumab administered
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab administered 7 days before vitrectomy
Trial: 23636185
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (1 mL methylprednisolone [40 mg] and 1 mL 2% lignocaine)
Trial: 16271721
Drug: Intramuscular oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular oxytocin
Trial: 30141230
Drug: Proton therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton therapy with uniform scanning or pencil beam scanning, prescribed doses of 50.4‐66.4 Gy(RBE) scaled to 50.4 Gy(RBE) for analysis.
Trial: 2031520
Drug: Ofloxacin, 400
RxNorm normalized name: Ofloxacin, 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin, 400 mg twice daily for 10 days
Trial: 10993998
Drug: Low-dose olanzapine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose olanzapine (2.5 to 7.5 mg/day)
Trial: 2864944
Drug: Single bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single bolus dose of vecuronium (10-50 micrograms kg-1)
Trial: 16616147
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 1800 mg/day
Trial: 20234330
Drug: 2-week antibiotic
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 2-week antibiotic treatment regimen
Trial: 20234330
Drug: 3-week antibiotic
RxNorm normalized name: etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-week antibiotic treatment regimen
Trial: 31132094
Drug: Oral contraception
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraception during treatment
Trial: 1560699
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir (ACV)
Trial: 10419245
Drug: Ibuprofen to
RxNorm normalized name: Ibuprofen to Go
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen to prevent recurrent febrile seizures
Trial: 27281084
Drug: Perineural dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perineural dexamethasone 5 mg
Trial: 31571571
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection of autologous, microfragmented adipose tissue
Trial: 9422205
Drug: Monocytic HLA-DR
RxNorm normalized name: Dr. Numb
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Monocytic HLA-DR expression measurement in dermatological patients receiving high dose systemic steroids
Trial: 19192477
Drug: Intramuscular haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular haloperidol alone
Trial: 15179345
Drug: Conventional anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anesthesia (G‐CA)
Trial: 23642943
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (2 g per day, single dosage of two 1 g pearls)
Trial: 2656902
Drug: Felodipine plain
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine plain tablet (10 mg)
Trial: 28941657
Drug: Complex decongestive
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex decongestive therapy (CDT)
Trial: 17410120
Drug: Mesoridazine 50
RxNorm normalized name: mesoridazine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesoridazine 50 mg
Trial: 28967272
Drug: Methotrexate monotherapy
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate monotherapy with glucocorticoid bridging
Trial: 10506877
Drug: Cefuroxime axetil,
RxNorm normalized name: Cefuroxime Axetil, 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil, 500 mg/d
Trial: 1951871
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin subcutaneously
Trial: 23807155
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg TAF
Trial: 6345308
Drug: Galphimia glauca
RxNorm normalized name: Galphimia Glauca
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galphimia glauca D4 therapy
Trial: 16787141
Drug: Anti-VEGF drugs
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-VEGF drugs
Trial: 26542030
Drug: Local treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local treatment
Trial: 1595785
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin plus low-dose aspirin
Trial: 17996241
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg niacin for 6 weeks
Trial: 9578254
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate 1 ml (10 mg) injected into the superior compartment of the temporomandibular joint
Trial: 30376089
Drug: Oral Polio
RxNorm normalized name: Oral Polio Vaccine
DrugBank: Oral Polio Vaccine (DB15864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Polio Vaccine (OPV) shedding
Trial: 26730967
Drug: Brushing and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brushing and immersion in water with a cleansing tablet
Trial: 18599016
Drug: Oral 13-cis-retinoic
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 13-cis-retinoic acid (RA) 10 mg twice daily for eight weeks
Trial: 15611537
Drug: Nurse delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse delivered analgesia with morphine via conventional route
Trial: 28385654
Drug: Routine preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine preoperative preparation for one week (CG)
Trial: 7792376
Drug: Guided imagery
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided imagery preparation
Trial: 30663606
Drug: CVT-301 84
RxNorm normalized name: CVT-6883
DrugBank: CVT-6883 (DB05936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVT-301 84 mg
Trial: 17243057
Drug: pegylated IFN-alpha-2b
RxNorm normalized name: Pegylated proline interferon alpha-2b
DrugBank: Ropeginterferon alfa-2b (DB15119)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: pegylated IFN-alpha-2b (1.0 micro g/kg)
Trial: 10319771
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution infusion (30 ml x kg(‐1) x h(‐1))
Trial: 1862584
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tenoxicam daily for ten days
Trial: 30463820
Drug: Atomization inhalation
RxNorm normalized name: Atomic Balm
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomization inhalation of terbutaline followed by nebulized inhalation of budesonide
Trial: 22209361
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg
Trial: 20826076
Drug: Juvenile drug
RxNorm normalized name: CUNNINGHAM CLAMP,JUVENILE,BARD #004052
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juvenile drug court (JDC) intervention
Trial: 16129614
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tube thoracostomy and streptokinase instillation (group B)
Trial: 7641922
Drug: Intrauterine insemination
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine insemination (IUI) with clomiphene citrate (CC)
Trial: 11135211
Drug: Cyclophosphamide 100
RxNorm normalized name: cyclophosphamide 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 100 mg/m(2) orally on Days 1-14, methotrexate 40 mg/m(2) and 5-fluorouracil 500 mg/m(2) intravenously on Days 1 and 8 every 4 weeks (CMF)
Trial: 16426468
Drug: Gabapentin 400
RxNorm normalized name: gabapentin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 400 mg 6 hourly
Trial: 9781802
Drug: Oral IFN-alpha
RxNorm normalized name: Alpha-caine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral IFN-alpha (200 IU daily sublingual dose)